Ado-trastuzumab Emtansine (T-DM1): An Antibody–Drug Conjugate (ADC) for HER2-Positive Breast Cancer
Year: 2014
Type: other
Source: Journal of Medicinal Chemistry
DOI: 10.1021/jm500766w
Authors: John M. Lambert, Ravi V. J. Chari
Institution: ImmunoGen (United States)
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2064839484
